{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:45:32Z","timestamp":1793979932588,"version":"4.8.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11438-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:13:31Z","timestamp":1761203611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Haemophilus influenzae global epidemiology and antimicrobial susceptibility patterns including ampicillin and amoxicillin-clavulanate resistance based on \u03b2-lactamase production, 2013\u20132022"],"prefix":"10.1186","volume":"25","author":[{"given":"Maroun M.","family":"Sfeir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"11438_CR1","unstructured":"CDC. Clinical overview of haemophilus influenzae disease. Centers for Disease Control and Prevention; 2024."},{"key":"11438_CR2","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.1093\/infdis\/jiaa537","volume":"224","author":"JR Gilsdorf","year":"2021","unstructured":"Gilsdorf JR. Hib vaccines: their impact on haemophilus influenzae type b disease. J Infect Dis. 2021;224:S321\u201330. https:\/\/doi.org\/10.1093\/infdis\/jiaa537.","journal-title":"J Infect Dis"},{"key":"11438_CR3","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1128\/AAC.00851-18","volume":"62","author":"H Honda","year":"2018","unstructured":"Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, Shiraishi T, Kuronuma K, Takahashi S, Takahashi H, Yokota S. Multiclonal expansion and high prevalence of beta-Lactamase-Negative haemophilus influenzae with high-Level ampicillin resistance in Japan and susceptibility to quinolones. Antimicrob Agents Chemother. 2018;62:e00851\u201318. https:\/\/doi.org\/10.1128\/AAC.00851-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"11438_CR4","unstructured":"World Health Organization. WHO updates list of drug-resistant bacteria most threatening to human health. 2024. Accessed online September 2024."},{"key":"11438_CR5","doi-asserted-by":"publisher","first-page":"947051","DOI":"10.3389\/fpubh.2022.947051","volume":"10","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Wang Y, Cheng J, Zhao X, Liang Y, Wu J. Molecular epidemiology and antimicrobial resistance of haemophilus influenzae in guiyang, guizhou, China. Front Public Health. 2022;10:947051. https:\/\/doi.org\/10.3389\/fpubh.2022.947051.","journal-title":"Front Public Health"},{"key":"11438_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fpubh.2020.00095","volume":"8","author":"X Li","year":"2020","unstructured":"Li X, Xiao S, Gu F, He W, Ni Y, Han L. Molecular epidemiology and antimicrobial resistance of haemophilus influenzae in adult patients in shanghai, China. Front Public Health. 2020;8:95. https:\/\/doi.org\/10.3389\/fpubh.2020.00095.","journal-title":"Front Public Health"},{"key":"11438_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/jac\/dkw565","volume":"72","author":"RSW Tsang","year":"2017","unstructured":"Tsang RSW, Shuel M, Whyte K, Hoang L, Tyrrell G, Horsman G, et al. Antibiotic susceptibility and molecular analysis of invasive haemophilus influenzae in canada, 2007 to 2014. J Antimicrob Chemother. 2017;72:1314\u20139. https:\/\/doi.org\/10.1093\/jac\/dkw565.","journal-title":"J Antimicrob Chemother"},{"key":"11438_CR8","unstructured":"CLSI. M100: Performance Standards for Antimicrobial Susceptibility Testing. Ed34. 2024."},{"key":"11438_CR9","unstructured":"EUCAST. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 14.0. 2024."},{"key":"11438_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12879-023-08930-5","volume":"24","author":"M Abavisani","year":"2024","unstructured":"Abavisani M, Keikha M, Karbalaei M. First global report about the prevalence of multi-drug resistant haemophilus influenzae: a systematic review and meta-analysis. BMC Infect Dis. 2024;24:90\u20135. https:\/\/doi.org\/10.1186\/s12879-023-08930-5.","journal-title":"BMC Infect Dis"},{"key":"11438_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/jac\/dkn274","volume":"62","author":"S Ladhani","year":"2008","unstructured":"Ladhani S, Heath PT, Ramsay ME, Slack MPE. Changes in antibiotic resistance rates of invasive haemophilus influenzae isolates in England and Wales over the last 20 years. J Antimicrob Chemother. 2008;62:776\u20139. https:\/\/doi.org\/10.1093\/jac\/dkn274.","journal-title":"J Antimicrob Chemother"},{"key":"11438_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jac\/dkl310","volume":"58","author":"WTM Jansen","year":"2006","unstructured":"Jansen WTM, Verel A, Beitsma M, Verhoef J, Milatovic D. Longitudinal European surveillance study of antibiotic resistance of haemophilus influenzae. J Antimicrob Chemother. 2006;58:873\u20137. https:\/\/doi.org\/10.1093\/jac\/dkl310.","journal-title":"J Antimicrob Chemother"},{"key":"11438_CR13","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1128\/JCM.01630-15","volume":"53","author":"D Skaare","year":"2015","unstructured":"Skaare D, Lia A, Hannisdal A, Tveten Y, Matuschek E, Kahlmeter G, Kristiansen B. Haemophilus influenzae with Non-Beta-Lactamase-Mediated Beta-Lactam resistance: easy to find but hard to categorize. J Clin Microbiol. 2015;53:3589\u201395. https:\/\/doi.org\/10.1128\/JCM.01630-15.","journal-title":"J Clin Microbiol"},{"key":"11438_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0732-8893(96)00026-0","volume":"24","author":"O Giger","year":"1996","unstructured":"Giger O, Mortensen JE, Clark RB, Evangelista A. Comparison of five different susceptibility test methods for detecting antimicrobial agent resistance among haemophilus influenzae isolates. Diagn Microbiol Infect Dis. 1996;24:145\u201353. https:\/\/doi.org\/10.1016\/0732-8893(96)00026-0.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"11438_CR15","doi-asserted-by":"publisher","first-page":"129223","DOI":"10.1128\/spectrum.01292-23japa","volume":"11","author":"AB Morton","year":"2023","unstructured":"Morton AB, Vareechon C, Pettengill MA. Is beta-lactamase testing acceptably accurate for predicting haemophilus influenzae susceptibility to beta-lactams? Epidemiological data from philadelphia, USA, 2017\u20132023. Microbiol Spectr. 2023;11:129223. https:\/\/doi.org\/10.1128\/spectrum.01292-23japa.","journal-title":"Microbiol Spectr"},{"key":"11438_CR16","doi-asserted-by":"publisher","first-page":"e00671","DOI":"10.1128\/AAC.00671-18","volume":"62","author":"K Kitaoka","year":"2018","unstructured":"Kitaoka K, Kimura K, Kitanaka H, Banno H, Jin W, Wachino J, Arakawa Y. Carbapenem-Nonsusceptible haemophilus influenzae with Penicillin-Binding protein 3 containing an amino acid insertion. Antimicrob Agents Chemother. 2018;62:e00671\u201318. https:\/\/doi.org\/10.1128\/AAC.00671-18. Print 2018 Aug.","journal-title":"Antimicrob Agents Chemother"},{"key":"11438_CR17","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.3346\/jkms.2024.39.e136","volume":"39","author":"S Lee","year":"2024","unstructured":"Lee S, Kim G, Kim JH, Kim M, Lee J. Characterization of Ceftriaxone-Resistant haemophilus influenzae among Korean children. J Korean Med Sci. 2024;39:e136. https:\/\/doi.org\/10.3346\/jkms.2024.39.e136.","journal-title":"J Korean Med Sci"},{"key":"11438_CR18","unstructured":"CLSI M52. Clinical and Laboratory Standards Institute. Verification of commercial microbial identification and antimicrobial susceptibility testing systems. 2015."},{"key":"11438_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1086\/646545","volume":"13","author":"MS Whitman","year":"1992","unstructured":"Whitman MS, Tunkel AR. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect Control Hosp Epidemiol. 1992;13:357\u201368. https:\/\/doi.org\/10.1086\/646545.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11438-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:13:33Z","timestamp":1761203613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11438-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11438"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11438-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1391"}}